论文部分内容阅读
目的探讨康艾注射液联合TP化疗治疗晚期非小细胞肺癌的临床效果。方法两组患者各60例均采用常规TP方案化疗,研究组患者在此基础上加用康艾注射液。结果研究组患者治疗总有效率明显高于对照组,研究组患者治疗后KPS评分明显高于对照组,数据经统计学比较差异有统计学意义(P﹤0.05)。两组患者不良反应发生率差异无统计学意义(P﹥0.05)。结论采用康艾注射液联合化疗治疗晚期非小细胞癌可提高化疗的整体疗效,改善患者的生存质量,临床医师应完善中西医结合治疗的理念,深入探讨更好的用药办法。
Objective To investigate the clinical effect of Kangai injection combined with TP chemotherapy in the treatment of advanced non-small cell lung cancer. Methods 60 patients in both groups were treated with routine TP regimen. Patients in the study group were given Kang Ai injection on this basis. Results The total effective rate of treatment group was significantly higher than that of the control group. The KPS score of the study group was significantly higher than that of the control group after treatment. The difference was statistically significant (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion Kangai injection combined with chemotherapy for advanced non-small cell lung cancer can improve the overall efficacy of chemotherapy and improve the quality of life of patients. Clinicians should improve the concept of integrated traditional Chinese and Western medicine and explore better medication.